DGNO.F Stock Overview
DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
DIAGNOS Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.21 |
| 52 Week High | CA$0.43 |
| 52 Week Low | CA$0.17 |
| Beta | -0.40 |
| 1 Month Change | 21.03% |
| 3 Month Change | -10.98% |
| 1 Year Change | 13.05% |
| 3 Year Change | -54.44% |
| 5 Year Change | -10.79% |
| Change since IPO | -82.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| DGNO.F | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -4.0% | 0.2% | 1.2% |
| 1Y | 13.0% | -8.1% | 24.9% |
Price Volatility
| DGNO.F volatility | |
|---|---|
| DGNO.F Average Weekly Movement | 12.9% |
| Healthcare Services Industry Average Movement | 9.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: DGNO.F's share price has been volatile over the past 3 months.
Volatility Over Time: DGNO.F's weekly volatility has decreased from 19% to 13% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | n/a | Andre Larente | www.diagnos.ca |
DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.
DIAGNOS Inc. Fundamentals Summary
| DGNO.F fundamental statistics | |
|---|---|
| Market cap | US$16.78m |
| Earnings (TTM) | -US$2.22m |
| Revenue (TTM) | US$143.38k |
115.1x
P/S Ratio-7.4x
P/E RatioIs DGNO.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DGNO.F income statement (TTM) | |
|---|---|
| Revenue | CA$196.45k |
| Cost of Revenue | CA$942.99k |
| Gross Profit | -CA$746.54k |
| Other Expenses | CA$2.29m |
| Earnings | -CA$3.04m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.04 |
| Gross Margin | -380.03% |
| Net Profit Margin | -1,547.90% |
| Debt/Equity Ratio | -100.9% |
How did DGNO.F perform over the long term?
See historical performance and comparison